Evidence check: Pharmakogenetik Medicheck in the context of Schlaf

Pharmacogenetics (PGx) can inform how certain drugs are metabolized, but evidence specific to sleep is limited. The provided context mentions the CYP2C19*2 poor metabolizer variant, which per CPIC guidelines affects drugs like clopidogrel and omeprazole—not typical sleep aids. Common sleep medications (e.g., zolpidem, melatonin) are metabolized by other enzymes (CYP3A4, CYP1A2) not covered in the context. MyBody-X tests are not clinical diagnostics; they analyze common SNPs for lifestyle insights. Thus, while PGx has strong human evidence for specific drug-gene pairs, its direct application to sleep is unclear. Evidence grade: mixed. Caveat: Always consult a physician before adjusting any medication based on genetic results.